BioSpace News Archive

Genetown

Pear Therapeutics to Participate in Evercore ISI HEALTHCONx Conference

Digital therapeutics panel discussion at the Evercore ISI HEALTHCONx Conference on Wednesday, November 28 at 6:00 p.m. at the Boston Harbor Hotel.

November 20, 2018
·
1 min read
Genetown

AVEO Oncology to Present at the 30th Annual Piper Jaffray Healthcare Conference

AVEO Oncology today announced that Michael Bailey, president and chief executive officer, will present at the 30th Annual Piper Jaffray Healthcare Conference in New York on Wednesday, November 28, 2018 at 2:30 p.m. Eastern Time.

November 20, 2018
·
3 min read
Genetown

Deciphera Pharmaceuticals, Inc. to Present at the 30th Annual Piper Jaffray Healthcare Conference

30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2018 at 2:30 PM ET at the Lotte New York Palace

November 20, 2018
·
2 min read
Business

Kraig Biocraft Laboratories Signs Pivotal Agreement to Import and Rear Silkworms in Vietnam

Agreement provides a location, skilled workers, security, and necessary oversight, for the Company to import and begin testing its first batch of recombinant spider silk silkworm eggs in Vietnam.

November 20, 2018
·
3 min read
Drug Development

Prior to Phase II Liver Cancer Data Release Can-Fite Brings on Board an Oncologist Expert

Data from Phase II study in advanced liver cancer are expected during Q1 2019

November 20, 2018
·
6 min read
Business

ProMIS Neurosciences Issues Year-to Date Update, Highlighting 2018 Accomplishments

Development of therapeutic antibodies for Alzheimer’s disease, Parkinson’s disease and ALS are top priorities for drug development and potential partnering

November 20, 2018
·
4 min read
Genetown

Permanent J Code Issued for Avedro’s Photrexa® Drug Formulations

J Code 2787, Effective January 1, 2019, Expected to Streamline Reimbursement and Expand Patient Access

November 20, 2018
·
4 min read
Pharm Country

Spheryx’s xSight Wins 2018 R&D 100 Award, Known as the Oscar of Innovation

Spheryx’s xSight, their new analytical instrument for particle characterization wins the R&D 100 Award that celebrates the top 100 revolutionary technologies in 2018.

November 20, 2018
·
2 min read
Business

Curaleaf Continues Rapid Expansion in Florida with 17th Store Opening

Curaleaf Holdings, Inc. announced today that the Company has opened its 17th medical marijuana dispensary in Florida.

November 20, 2018
·
2 min read
Drug Development

Theravance Biopharma Announces First Patient Dosed in Phase 2 Study of TD-1473 in Patients with Crohn’s Disease

Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”) today announced dosing of the first patient in a Phase 2 clinical trial of TD-1473 in patients with Crohn’s disease.

November 20, 2018
·
8 min read